Key result
In women with surgical menopause, renal artery pulsatility indices significantly increased over 2 years without hormone replacement therapy (P<.001), while hepatic indices remained unaffected.
Why the study?
Does hormone replacement therapy prevent changes in hepatic and renal artery pulsatility indices in women with surgical menopause?
Cohort (n=80)
Does hormone replacement therapy prevent changes in hepatic and renal artery pulsatility indices in women with surgical menopause?
p-value: p=<.001
Hormone replacement therapy appears to prevent the rise in renal artery pulsatility indices observed in women following surgical menopause.
May link surgical menopause without HRT to rising renal pulsatility; hypothesis-generating and leaves open any HRT effect.
OBJECTIVE: To investigate the flow velocity waveform changes of the hepatic and renal arteries in women with surgical menopause who received hormone replacement therapy versus those who did not. METHODS: Eighty women who had undergone surgical menopause were divided into 2 groups. The first group (n = 38) consisted of patients who did not receive estrogen treatments after surgery; patients in the second group (n = 42) did receive treatments. The hepatic and renal arteries of patients in both groups were examined by duplex Doppler ultrasonography before the commencement of hormone replacement therapy and after 2 years of treatment, and the pulsatility indices were calculated. RESULTS: No significant differences were detected in the renal and hepatic artery pulsatility indices of patients in the estrogen treatment group (group 2) before and after total abdominal hysterectomy and bilateral salpingo-oophorectomy (P > .05). No significant differences in preoperative and postoperative hepatic arterial pulsatility indices were detected among patients in group 1 (P > .05). Renal artery pulsatility indices measured before and after total abdominal hysterectomy and bilateral salpingooophorectomy did show a statistically significant difference in group 1 (P < .001). In addition, a statistically significant difference was detected before and after surgery in both groups when pulsatility indices were measured at the second-year control dose. CONCLUSIONS: Hepatic arterial pulsatility indices are not affected in postmenopausal women, but renal artery pulsatility indices rise to some extent in women not receiving hormone replacement therapy.
No takes yet. Share an insight, caveat, or question.
Mihmanlı et al. (2002) conducted a cohort in Surgical menopause (n=80). Hormone replacement therapy vs. No hormone replacement therapy was evaluated on Pulsatility indices of hepatic and renal arteries (p=<.001). In women with surgical menopause, renal artery pulsatility indices significantly increased over 2 years without hormone replacement therapy (P<.001), while hepatic indices remained unaffected.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: